Massar Alsamraae

Massar Alsamraae

Auto-generated profile, based on publicly available information

Massar Alsamraae

Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2025 in Cancer Discovery
Verified
Journal Article
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
In patients with non–small cell lung cancer (NSCLC), the relationship between tumor metabolism and clinical outcomes is unknown. Here, 13C-labeled nutrients were intraoperatively infused into more than 90 patients with surgically resectable pulmonary lesions, and metabolic properties of resected tumors were correlated with survival. In NSCLCs infused with 13C-glucose, high 13C enrichment in tricarboxylic acid (TCA) cycle intermediates conferred a HR of 3.8 for early death, typically with metastasis. To test whether these features reflect requirements for metastasis, we generated patient-derived xenografts that spontaneously metastasize to multiple organs. Treatment with an electron transport chain (ETC) inhibitor reduced glucose-derived TCA cycle labeling but did not suppress subcutaneous tumor growth. However, ETC blockade reduced the abundance of circulating cancer cells and suppressed xenograft metastatic burden in distant organs. Our data demonstrate that isotope labeling can identify metabolic properties associated with metastasis in patients and that blocking the ETC suppresses metastasis in mice. Significance: Intraoperative 13C-glucose infusions in patients with NSCLC show that tumors with high labeling of TCA cycle intermediates progress rapidly, resulting in metastasis and early death. Blocking this pathway suppresses metastasis of human NSCLC cells in mice.

17 June 2026
Verified
Other
Open access
PDF file
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 2). Epithelial and myeloid cell contributions to gene expression and 13C labeling features.

17 June 2026
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 3). Overall and recurrence-free survival summary.

17 June 2026
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
In patients with non–small cell lung cancer (NSCLC), the relationship between tumor metabolism and clinical outcomes is unknown. Here, 13C-labeled nutrients were intraoperatively infused into more than 90 patients with surgically resectable pulmonary lesions, and metabolic properties of resected tumors were correlated with survival. In NSCLCs infused with 13C-glucose, high 13C enrichment in tricarboxylic acid (TCA) cycle intermediates conferred a HR of 3.8 for early death, typically with metastasis. To test whether these features reflect requirements for metastasis, we generated patient-derived xenografts that spontaneously metastasize to multiple organs. Treatment with an electron transport chain (ETC) inhibitor reduced glucose-derived TCA cycle labeling but did not suppress subcutaneous tumor growth. However, ETC blockade reduced the abundance of circulating cancer cells and suppressed xenograft metastatic burden in distant organs. Our data demonstrate that isotope labeling can identify metabolic properties associated with metastasis in patients and that blocking the ETC suppresses metastasis in mice.Significance:Intraoperative 13C-glucose infusions in patients with NSCLC show that tumors with high labeling of TCA cycle intermediates progress rapidly, resulting in metastasis and early death. Blocking this pathway suppresses metastasis of human NSCLC cells in mice.

2 April 2025
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 2). Transcriptomic data for NSCLC and adjacent lung tissue fragments.

2 April 2025
Verified
Other
Open access
LCLing Cai
Ling Cai
NHNia G. Hammond
Nia G. Hammond
ATAlpaslan Tasdogan
Alpaslan Tasdogan
MAMassar Alsamraae
Massar Alsamraae
CYChendong Yang
Chendong Yang
RDRalph J. DeBerardinis
Ralph J. DeBerardinis
(Related to Figure 3). TCA cycle metabolite abundance does not correlate with overall survival.